These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1245 related articles for article (PubMed ID: 26873912)

  • 1. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
    Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
    J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.
    Schibilsky D; Lausberg H; Haller C; Lenglinger M; Woernle B; Haeberle H; Rosenberger P; Walker T; Schlensak C
    Artif Organs; 2015 Aug; 39(8):660-3. PubMed ID: 26147682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical circulatory support with the Impella 5.0 and the Impella Left Direct pumps for postcardiotomy cardiogenic shock at La Pitié-Salpêtrière Hospital.
    David CH; Quessard A; Mastroianni C; Hekimian G; Amour J; Leprince P; Lebreton G
    Eur J Cardiothorac Surg; 2020 Jan; 57(1):183-188. PubMed ID: 31270535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit.
    Bresson D; Sibellas F; Farhat F; Jegaden O; Kirkorian G; Bonnefoy E
    Arch Cardiovasc Dis; 2011 Aug; 104(8-9):458-64. PubMed ID: 21944148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
    Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
    Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery.
    Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I
    J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock.
    Meyns B; Dens J; Sergeant P; Herijgers P; Daenen W; Flameng W
    Thorac Cardiovasc Surg; 2003 Dec; 51(6):312-7. PubMed ID: 14669126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the Impella 5.0 with a right axillary artery approach as bridge to long-term mechanical circulatory assistance.
    Pozzi M; Quessard A; Nguyen A; Mastroianni C; Niculescu M; Pavie A; Leprince P
    Int J Artif Organs; 2013 Oct; 36(9):605-11. PubMed ID: 23918265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microaxial devices for ventricular failure: a multicentre, population-based experience.
    Higgins J; Lamarche Y; Kaan A; Stevens LM; Cheung A
    Can J Cardiol; 2011; 27(6):725-30. PubMed ID: 21983112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
    Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with temporary right ventricular mechanical circulatory support.
    Bhama JK; Bansal U; Winger DG; Teuteberg JJ; Bermudez C; Kormos RL; Bansal A
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1885-1891. PubMed ID: 29861112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock.
    Takeda K; Garan AR; Topkara VK; Kirtane AJ; Karmpaliotis D; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takayama H
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):591-596. PubMed ID: 27818380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridge to durable left ventricular assist device for refractory cardiogenic shock.
    Yoshioka D; Takayama H; Garan AR; Topkara VK; Han J; Li B; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    J Thorac Cardiovasc Surg; 2017 Apr; 153(4):752-762.e5. PubMed ID: 27988030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The short-term pulsatile ventricular assist device for postcardiotomy cardiogenic shock: a clinical trial in China.
    Xiao XJ; Luo ZX; Ye CX; Fan RX; Yi DH; Ji SY; Wu RB; Cheng AH; Huang HL; Wu YH; Zhang XH; Zheng SY
    Artif Organs; 2009 Apr; 33(4):373-7. PubMed ID: 19335414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirty-five day Impella 5.0 support via right axillary side graft cannulation for acute cardiogenic shock.
    Castillo-Sang MA; Prasad SM; Singh J; Ewald GA; Silvestry SC
    Innovations (Phila); 2013; 8(4):307-9. PubMed ID: 24145977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.